Treatments and Severe Outcomes for Patients Diagnosed With MIS-C at Four Children's Hospitals in the United States, March 16, 2020-March 10, 2021.
Ami B ShahJoseph Y AbramsShana Godfred-CatoAmber KunkelTeresa A HammettMaria A PerezHui-Mien HsiaoNadine BaidaChristina A RostadWassim BallanKaleo EdeFederico R LahamCarol M KaoMatthew E OsterErmias D BelayPublished in: The Pediatric infectious disease journal (2023)
Treatments for MIS-C differed by hospital, patient characteristics and illness severity. When IVIG and low-dose steroids were administered in combination or low-dose steroids were administered alone within 1 day of hospitalization, the risk of subsequent severe outcomes was decreased.